Skip to main content

Table 1 Clinico-pathological characteristics of patients with endometrial cancer

From: Endometrial cancer prognosis correlates with the expression of L1CAM and miR34a biomarkers

Clinicopathological characteristics No recurrence Recurrence
N (%) N (%)
Age at diagnosis
 median (range) 65 (40–84) 68 (48–88)
  ≤ 67 yrs 34 (60.7) 27 (47.4)
  > 67 yrs 22 (39.3) 30 (52.6)
BMI
 median (range) 28 (18–53) 31 (21–80)
Grade
 G1 1 (1.8) 6 (10.6)
 G2 19 (33.9) 17 (29.8)
 G3 36 (64.3) 34 (59.6)
Histology
 Adenocarcinoma (ADK) 46 (82.1) 46 (80.7)
 Others 10 (17.9) 11 (19.3)
Stage
  ≤ IB 21 (37.5) 32 (56.1)
  ≥ IB 35 (62.5) 25 (43.9)
Adjuvant treatment
 None 11 (19.6) 15 (26.3)
 Radiotherapy 30 (53.6) 22 (38.6)
 Chemotherapy 8 (14.3) 11 (19.3)
 Radiation and chemotherapy 7 (12.5) 9 (15.8)
Lymph nodes
 Positive 7 (12.5) 6 (10.5)
 Negative 49 (87.5) 51(89.5)
Washing
 Positive 7 (12.5) 6 (10.5)
 Negative 49 (87.5) 51 (89.5)
LVSI
 Positive 13 (23.2) 13 (22.8)
 Negative 43 (76.8) 38 (66.7)
Hypertension
 Yes 27 (48.2) 33 (57.9)
 No 29 (51.8) 24 (42.1)
Diabetes
 Yes 6 (10.7) 9 (15.8)
 No 50 (89.3) 48 (84.2)